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Edited by Felix WielandAbstract The Rybp protein has been promoted as a Polycomb
group (PcG)-associated protein, but its molecular function has
remained elusive. Here we show that Rybp is a novel ubiquitin
binding protein and is itself ubiquitinated. The Rybp interacting
PcG protein Ring1B, a known ubiquitin E3 ligase, promotes
Rybp ubiquitination. Moreover, one target of Rybp’s ubiquitin
binding domain appears to be ubiquitinated histone H2A; this
histone is a substrate for Ring1B’s E3 ligase activity in associa-
tion with gene silencing processes. These ﬁndings on Rybp pro-
vide a further link between the ubiquitination system and PcG
transcriptional repressors.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Histone H2A1. Introduction
Post-translational modiﬁcation of proteins through the
attachment of chemical groups or small polypeptides has been
implicated in the regulation of diverse cellular processes
including signal transduction, intracellular transport, tran-
scription, and DNA repair. The attachment of ubiquitin, a
76 amino acid polypeptide, to lysine residues of target proteins
originally was described as a signal for proteasomal-mediated
degradation (reviewed in [1,2]). However, it is now recognized
that diﬀerent modes of ubiquitin conjugation exist, including
the attachment of lysine 48-, lysine 29-, lysine 63-, or lysine
6-linked polyubiquitin chains or the attachment of single moi-
eties of ubiquitin (reviewed in [3–7]). While the lysine 48-linkedAbbreviations: CFP, cyan ﬂuorescent protein; NZF, Npl4 zinc ﬁnger;
ORF, open reading frame; PcG, Polycomb group; PRC1, Polycomb
repressive group complex 1; TS, trophoblast stem; UBD, ubiquitin
binding domain; uH2A, ubiquitinated histone H2A; YFP, yellow
ﬂuorescent protein
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doi:10.1016/j.febslet.2006.10.027and lysine 29-linked polyubiquitin chain attachments are most
often correlated with protein degradation, other forms of ubiq-
uitin attachment result in changes in function, interactions,
and/or subcellular localization of the modiﬁed protein ([8,9];
see also [10,11]).
Ubiquitin conjugation is brought about through an enzy-
matic cascade involving an E1 activating enzyme, an E2 conju-
gating enzyme, and, in most cases, an E3 ligase that confers
substrate speciﬁcity (reviewed recently in [1,2]). Ubiquitinated
proteins are known to interact with adapter/receptor proteins
that harbor domains capable of binding to the modiﬁcations
in a non-covalent manner (reviewed recently in [12–17]). Sev-
eral distinct types of ubiquitin binding domains (UBD) have
been described including the UIM, CUE, UBA, UEV, PAZ,
NZF, and others. Current models suggest that the adapter/
receptor proteins containing these UBDs translate the ubiqui-
tin signals of their target proteins by altering function, locali-
zation or stability (reviewed in [12–16,18]).
Here we assessed whether Rybp (for Ring1 and YY1 binding
protein; also known as DEDAF), by virtue of its harboring a
putative UBD in its amino terminal region, is able to function
as a ubiquitin binding protein. Rybp ﬁrst was isolated as an
interacting partner for Polycomb group (PcG) proteins, specif-
ically associating with those PcG proteins that have been as-
signed to the PcG PRC1 complex, including Ring1A,
Ring1B (a.k.a. Rnf2), and M33 ([19]; for reviews on PcG com-
plexes see [20–24]). Historically classiﬁed as transcriptional co-
repressors that function to establish a heritable repressed state
of key developmental genes, PcG proteins are now implicated
in the processes of proliferation, survival, self-renewal, and
tumorigenesis (for reviews see [20–27]). On the molecular level,
transcriptional regulation by PcG proteins is achieved in part
through their abilities to post-translationally modify histones.
For example, the PcG protein Ring1B has been reported to
promote monoubiquitination of histone H2A, with this modi-
ﬁcation playing an important role in both X inactivation and
Hox gene silencing [28–31]. The Ring1B-related Ring1A pro-
tein has been shown to stimulate the E3 ligase activity of
Ring1B towards histone H2A, as has another Polycomb
repressive group complex 1 (PRC1) member, Bmi1 ([31] also
see [32,33]). The role of Rybp in PcG complexes has remained
elusive, although it has gained support in vivo in a recent
report on Drosophila Rybp. Speciﬁcally, transcriptional repres-
sion activity of dRybp is strictly dependent on the presence of
PRC1-complex members [34]. Moreover, ﬂies that lacked
dRybp showed some homeotic transformations, a phenotypeblished by Elsevier B.V. All rights reserved.
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in vivo [34].
We now show that Rybp has an NZF UBD that mediates its
interactionwith ubiquitin and ubiquitinated proteins. ThisNZF
also promotes the ubiquitination of Rybp itself, a modiﬁcation
that is enhanced by Ring1B. The integrity of Rybp’s NZF ap-
pears to be important for the subnuclear localization of Rybp
and Ring1B to Polycomb group bodies. Binding assays indicate
that one target of Rybp’s ubiquitin binding domain is ubiquiti-
nated histone H2A. Consistent with this, Rybp, Ring1B, and
ubiquitinated histoneH2Acan be found together on the inactive
X chromosome in trophoblast stem cells. Together, these ﬁnd-
ings are in line with the emerging theory that Rybp may partic-
ipate in PcG protein-mediated transcriptional repression (see
also [19,34]), and suggest that this function for Rybp is tied to
its role as a ubiquitin binding protein.2. Materials and methods
2.1. Plasmid construction
Rybp cDNA was ampliﬁed by RT-PCR from total mouse prostate
RNA and cloned in frame with a 3 0 FLAG tag in pcDNA 3.1+ or with
a 5 0 GST moiety in pGEX-5X-1. To generate mutations within the
Rybp’s NZF UBD (TF-AA mutation), the QuikChange Site Directed
Mutagenesis Kit (Stratagene) was used with the following primers
(with underlined mutations): GATTGTAGCGTCTGCGCCGCTAG-
GAACAGCGCCGAA (sense) and TTCGGCGCTGTTCCTAGC-
GGCGCAGACGCTACAATC (antisense). The Ring1A cDNA was
ampliﬁed by RT-PCR from mouse liver RNA and was cloned in
frame with a 5 0 FLAG tag in pcDNA3.1+. pcDNA-Myc-Ring1B was
a gift from H. Koseki, RIKEN Yokohama Institute. PCR-generated
Rybp or Rybp(TF-AA) were subcloned in frame into a pEYFP-C1
plasmid carrying a 5 0 yellow ﬂuorescent protein (YFP) sequence.
PCR-generated Ring1B was subcloned in frame into a pECFP-C1
plasmid carrying a 5 0 cyan ﬂuorescent protein (CFP) sequence.
pKH3-Myc-Ub was a gift from D. Germain, Mount Sinai School of
Medicine). PCR-generated ubiquitin open reading frame (ORF) was
cloned into pcDNA-His/C, in frame with a 5 0 6 ·His tag. Further
details about plasmid construction are available upon request.
2.2. Biosensor binding experiments
Biosensor binding experiments were performed at 20 C using a
BIACORE 2000 (Biacore AB, Uppsala, Sweden) equipped with a
research-grade CM4 sensor chip. GST-fusions of the RYBP protein,
the TF-AA mutant protein, and the Npl4-NZF domain were expressed
in BL21(DE3) CodonPlus (Stratagene) cells using the auto-induction
method [35]. Half liter cultures were started from single colonies and
allowed to grow 10 h at 37 C, and then switched to room temperature
for growth to saturation (overnight). Cell pellets were lysed in 40 ml of
lysis buﬀer (50 mM Tris 8.0, 150 mM NaCl, 1 mM DTT, 0.5% NP-40,
5% glycerol and a cocktail of protease inhibitors (leupeptin, PMSF,
aprotinin, and pepstatin), and then cleared of cell debris by centrifuga-
tion. About 3000 RU anti-GST Ab was immobilized to the CM4 chips
using amine-coupling chemistry. GST-fusion proteins (or recombinant
GST alone, reference) were captured directly on the antibody surfaces
at densities of about 1000 RU from soluble Escherichia coli lysates di-
luted in running buﬀer (25 mM Tris pH 8.0, 150 mM NaCl, 5 mM
bME, 10 lM ZnCl2, 0.2 mg/ml BSA and 0.01% P20). Pure recombi-
nant wildtype ubiquitin and the I44A mutant were expressed and puri-
ﬁed as described previously [36], and injected in running buﬀer in
triplicate over the three surfaces at concentrations of 0–1000 lM
(50 ll/min). Data were collected at a rate of 2 Hz during the 25 s asso-
ciation and dissociation phases.
2.3. In vitro binding assays
For the ubiquitin binding assays, 25 lg GST-Rybp or GST-
Rybp(TF-AA) were immobilized onto glutathione sepharose beads
and incubated with 250 lg total protein extract from HeLa cells, either
non-transfected or over-expressingMyc-tagged ubiquitin, in GST bind-ing buﬀer (100 mMTris pH 7.4, 200 mMNaCl, 1%NP-40, 5 mM bME,
1· protease inhibitor cocktail, Roche) or with binding buﬀer alone.
Samples were incubated for 1 h at 4 C, washed with binding buﬀer,
and loaded onto SDS–PAGE followed by Western blotting analysis
using an antibody directed against ubiquitin (1:100, U5279 SIGMA).
For the ubiquitinated histone H2A binding studies, nucleosomal his-
tones were prepared by subcellular fractionation into nuclear extracts
and nuclear pellets, and pellets were then resuspended in buﬀer C
(20 mM Tris pH 8.0, 1.5 mM MgCl2, 0.42 M NaCl, 0.5 mM DTT,
0.2 mM PMSF, 0.2 mM EDTA) and brieﬂy sonicated to bring nucle-
osomes in solution. Approximately 25 lg GST-Rybp or GST-
Rybp(TF-AA) proteins were then incubated with 500 lg of histones
in GST-binding buﬀer for one hour at 4 C. Samples were then washed
and subjected to Western blotting analysis using antibodies directed
against histone H2A (1:500; 07-146, Upstate) or against ubiquityl-his-
tone H2A, clone E6C5 (1:100; 05-678, Upstate).2.4. Cell culture-based assays
HeLa cells were transfected with the indicated constructs using Fu-
Gene (Roche) or the calcium phosphate precipitation method. Forty-
eight hours post-transfection cells were collected, washed with PBS,
lysed in PG buﬀer (50 mM Tris pH 8.0, 150 mM NaCl, 0.5% NP-40,
5 mM EDTA and protease inhibitors), incubated on ice for 20 min
and centrifuged.
For more stringent conditions in the in vivo ubiquitination assay,
cells were lysed with 100 ll SDS buﬀer (1:3 ratio of Buﬀer 1: 5%
SDS, 150 mM Tris pH 6.9, 30% glycerol, to Buﬀer 2: 25 mM Tris
pH 8.3, 50 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS), with protease inhibitors, and incubated on ice for 15 min. Ly-
sates were sonicated twice on ice and then boiled for 2 min. Proteins
were then diluted 1:10 with dilution buﬀer (50 mM Tris pH 7.5,
150 mM NaCl, 0.5% NP-40, 50 mM NaF and protease inhibitors).
For immunoprecipitations, equal amounts of proteins were pre-
cleared for 20 min with 30 ll protein G agarose (Sigma), and
FLAG-tagged proteins were immunoprecipitated for 90 min at 4 C
using 30 ll of agarose-conjugated anti-FLAG antibody (Sigma). Sam-
ples were washed with PG buﬀer (or dilution buﬀer for the high strin-
gency assay) and then loaded onto SDS–PAGE for Western blot
analysis using antibodies directed against Rybp/DEDAF (1:1000;
AB3637 Chemicon), the Myc tag (1:100; OP10 Calbiochem), or the
HA tag (1:300; sc-805 Santa Cruz).2.5. Subcellular localization analysis
U2OS cells were grown on glass coverslips in 6-well dishes until 70%
conﬂuent and then transfected using FuGene with 100 ng of pEYFP/
C1-Rybp or pEYFP/C1-Rybp(TF-AA) with or without pECFP/C1-
Ring1B, following the manufacturer’s instructions. Eighteen hours
post-transfection, cells were washed twice with PBS, coverslips were re-
moved from the wells and cells were ﬁxed in 2% formaldehyde, 4% su-
crose in PBS for 5 min. Coverslips were then washed twice with PBS
and mounted on glass slides, and images were acquired using a
CDD camera mounted on an Olympus 1·81 microscope. Images were
then processed using IPLab software (Scanalytics). To determine the
levels of expression of the ﬂuorescent fusion proteins, the remaining
cells in each transfected well were collected, lysed in PG buﬀer, and
subjected to Western blotting analysis using antibodies directed against
Rybp (1:1000; AB3637 Chemicon) or Ring1B (kind gift of Dr. H. Kos-
eki, RIKEN Yokohama Institute).
For the trophoblast stem (TS) cell studies, XX TS cells (kind gift of
K. Huynh and J. Lee, Harvard) were grown on irradiated mouse
embryonic ﬁbroblasts (MEFs) in TS medium (RPMI 1640 with 20%
fetal bovine serum, 1 mM sodium pyruvate, 10 lM b-ME, 2 mM L-
glutamine) plus 25 ng/ml FGF4 and 1 lg/ml heparin freshly added as
previously described [37]. Preparation of TS cells for immunoﬂuores-
cence analysis was performed as previously described [29]. Dilutions
of primary antibodies were as follows: anti-Ring1B/RNF2 [38]; kind
gift of H. Koseki, RIKEN Yokohama Institute) 1:2, anti-ubiquityl-
Histone H2A, clone E6C5 (05–678, Upstate) 1:50, anti-RYBP
(AB3637, Chemicon) 1:100. Secondary antibodies GAR IgG-568
1-11036 and GAM IgG-488 A-11029 from Molecular Probes were
diluted 1:200, and DAM IgM-FITC 715-095-140 from Jackson Immu-
noResearch Laboratories, Inc. was diluted 1:50. Immunoﬂuorescence
was recorded using a Zeiss AxioCam MRc Camera running MRGrab
1.0.0.4 on a Leica DMRB compound ﬂuorescence microscope.
Fig. 1. Rybp can bind to ubiquitin and ubiquitinated proteins in vitro.
(A) Aligned amino acid sequences of the NZF domains of several
Rybp orthologs (Homo sapiens, NCBI Protein Database NP_036366:
Mus musculus, NCBI Protein Database NP_062717; Xenopus tropi-
calis, NCBI Protein Database P_001016846; Danio rerio NCBI Protein
Database NP_958474; Drosophila melanogaster, from FlyBase, gene
CG12190). Consensus sequences for NZF motifs, as well as for the
subset of NZF motifs that speciﬁcally recognize ubiquitin (Ub),
are shown below. The zinc-coordinating cysteines are boxed, the
amino acids that function as a molecular signature for NZF modules
are in bold, and the critical residues of NZFs involved in ubiquitin
binding are marked by arrows. U = hydrophobic residue. (B) Biosensor
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3.1. Rybp harbors an NZF UBD with a dual function
Examination of Rybp’s coding region sequence reveals the
presence of a zinc ﬁnger of the NZF (for Npl4 zinc ﬁnger) type
(x(n)–W–x–C–x(2)–C–x(3)–N–x(6)–C–x(2)–C–x(n)) (Fig. 1A).
Recently it has been shown that a subset of NZF domains, spe-
ciﬁcally those containing a 13TF14/U25 motif surrounding the
zinc coordination site, possess ubiquitin binding activity [39–
42]. Because the NZF 13TF14/U25 motif is conserved in Rybp
orthologs throughout evolution (Fig. 1A; see arrows indicating
the 13TF14/U25 residues; U = hydrophobic), we asked whether
Rybp was indeed capable of ubiquitin binding in vitro. Bio-
sensor experiments revealed that an immobilized GST-Rybp
fusion protein was able to bind to free ubiquitin in solution
with a dissociation constant of 479 ± 4 lM (Fig. 1B, upper
graph, squares). Although relatively weak, this low aﬃnity
interaction is in the range of that reported for other ubiquitin
binding domains (UBDs) (see for example the GST-Npl4 NZF
control in Fig. 1B, upper graph, circles) and may facilitate
reversibility and network disassembly (reviewed in [12–
14,16,18]). As has been described for other ubiquitin binding
types of NZFs [39], mutation of the threonine and phenylala-
nine residues within the 13TF14/U25 motif of the Rybp protein
(TF-AA mutant) completely abrogates binding to ubiquitin
(Fig. 1B, upper graph, diamonds). Finally, the structure of
the Npl4 NZF domain in complex with ubiquitin indicates that
it binds at the essential I44A surface of ubiquitin [40]. In agree-
ment with this, wildtype Rybp protein is unable to bind an
I44A ubiquitin mutant (Fig. 1B, lower graph, squares).
Having shown that Rybp can bind to free ubiquitin in solu-
tion via its NZF, we next asked whether Rybp also could bind
to ubiquitinated proteins (Fig. 1C). Whole cell lysates were
prepared from HeLa cells that were either non-transfected or
transfected with Myc-tagged ubiquitin, and equal amounts of
these lysates were applied to columns of immobilized GST-
Rybp or GST-Rybp(TF-AA). Bound proteins were resolved
by SDS–PAGE followed by Western blotting with an anti-
ubiquitin antibody. As shown in Fig. 1C, GST-Rybp is capa-
ble of associating with a smear of ubiquitinated proteins (top
panel, lane 1) which intensiﬁes when the proteins are harvested
from cells transfected with ubiquitin (top panel, lane 2). This
smear is not apparent when the NZF mutant of Rybp (GST-
Rybp(TF-AA) is employed (Fig. 1C, top panel, lanes 4–5)
nor when the GST fusions are incubated with binding buﬀer
alone (Fig. 1C, top panel, lanes 3 and 6). Taken together, these
ﬁndings suggest that Rybp can bind to ubiquitin and to ubiq-
uitinated proteins in vitro in an NZF-dependent manner.isotherms showing wildtype ubiquitin (top) or I44A-ubiquitin mutant
(bottom) binding to immobilized GST-Rybp (squares), GST-
Rybp(TF-AA) (diamonds) and GST-Npl4 NZF (circles, positive
control). Dissociation constants and their errors were derived by
ﬁtting simple 1:1 models to the equilibrium binding data (solid lines)
[39]. Background binding to a control GST surface was negligible (not
shown). (C) Western blotting (WB) analysis of GST-pulldowns
performed using GST-Rybp and GST-Rybp(TF-AA) and total protein
extracts from HeLa cells either non-transfected (NT) or transfected
with Myc-tagged ubiquitin (Ub). Recovered proteins were probed with
an antibody directed against ubiquitin. Equal levels of GST-Rybp
(lanes 1–3) and GST-Rybp(TF-AA) (lanes 4–6) were used in all
samples, as indicated by Ponceau Staining (bottom panel). Molecular
weight is shown in kDa on the left.
b
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ubiquitinated proteins in vivo (Fig. 2A). HeLa cells were trans-
fected with FLAG-tagged Rybp with or without Myc-tagged
ubiquitin, and lysates were immunoprecipitated with anti-
FLAG antibody and blotted with anti-Myc tag antibody. As
shown in Fig. 2A, lane 2, the co-introduction of Rybp and
ubiquitin yielded a smear of ubiquitinated proteins in the
anti-FLAG immunoprecipitates that was undetectable when
the transfected proteins were introduced individually
(Fig. 2A, lanes 1 and 4). Notably, this smear is signiﬁcantly
diminished in the FLAG immunoprecipitates from Rybp-
(TF-AA)FLAG + ubiquitin transfected cells (Fig. 2A, lane 3).
To ensure that equivalent levels of the wildtype and mutant
versions of Rybp were immunoprecipitated in these studies,
the FLAG immunoprecipitates also were probed with an anti-
Rybp antibody (Fig. 2B, top panel). In addition to conﬁrming
this (see bands marked by open circle in Fig. 2B, top panel),
the anti-Rybp antibody also detected a higher molecular
weight band in the immunoprecipitates from wildtype Rybp +Fig. 2. Rybp binds to ubiquitinated proteins, and is itself monoubiq-
uitinated, in vivo. Western blotting analysis of FLAG immunoprecip-
itates of HeLa cells transfected with the indicated plasmids, and
probed with the anti-Myc antibody in (A) or the anti-Rybp antibody in
(B), upper panel. In the middle panel in (B), FLAG-immunoprecipi-
tations were performed on protein lysates prepared under high
stringency conditions, and probed with the anti-Myc antibody. These
lysates were also probed with the anti-Rybp antibody (B, lower panel)
to conﬁrm equal representation of the transfected Rybp proteins. The
starred bands in (B) represent the monoubiquitinated form of Rybp;
the bands marked by open circles in the upper panel of (B) represent
unmodiﬁed, Flag-tagged Rybp or Rybp(TF-AA). Molecular weight is
shown in kDa on the left. IP = immunoprecipitated; WB =Western
blotting; HC = heavy chain; NS = non-speciﬁc.ubiquitin transfected cells only (see band marked by asterisk in
Fig. 2B, top panel, lane 2). Given the apparent molecular
weight of this band (48 kDa), we suspected that it could
represent RybpFLAG modiﬁed by one moiety of Myc-tagged
ubiquitin. This was veriﬁed when the FLAG immunoprecipita-
tions were performed under high stringency buﬀer conditions,
and the immunoprecipitates were blotted with the anti-Myc
tag antibody (Fig. 2B, middle panel, lane 2, starred band).
Accordingly, it appears that Rybp can be monoubiquitinated.
Interestingly, modiﬁcation of Rybp also depends upon its hav-
ing an intact NZF, since the TF-AA mutant does not appear to
be monoubiquitinated (Fig. 2B, all panels, lane 3) (note that the
TF-AA mutation does not involve any lysine residues that
could be ubiquitination targets). This ‘‘coupling’’ between
ubiquitin binding by and ubiquitination of a UBD-containing
protein, with both processes dependent upon the UBD, has
been reported previously (reviewed in [12–14,16]; also see [42]
for coupling reported for NZF UBDs). Recently, it has been
shown that (mono)ubiquitination of UBD-containing proteins
can serve a negative regulatory role, by promoting intramolec-
ular interactions and preventing constitutive recognition of free
ubiquitin and of ubiquitinated targets [43]. However, mono-
ubiquitination of UBD-containing proteins may have other
functional consequences upon these ubiquitin binding proteins
as well, including mediating signal ampliﬁcation (reviewed in
[12–14,16]). The ramiﬁcations of Rybp’s modiﬁcation by ubiq-
uitin remain to be determined.3.2. Eﬀects of disrupting Rybp’s ability to bind to and to be
modiﬁed by ubiquitin
Having shown that the Rybp(TF-AA) mutant does not
appear to recognize ubiquitin or to be ubiquitinated, we next
asked whether loss of these abilities aﬀect some of the known
properties of Rybp (Figs. 3 and 4). First we assessed whether
this mutation aﬀects Rybp’s ability to interact with the Poly-
comb group (PcG) proteins Ring1A and Ring1B (also see
[19]). FLAG-tagged versions of wildtype or mutant Rybp were
tested for interaction with HA-tagged Ring1A or Myc-tagged
Ring1B after transfection into HeLa cells. Wildtype Rybp and
the Rybp(TF-AA) mutant were capable of immunoprecipitat-
ing comparable amounts of Ring1A (Fig. 3, top panel, lanes 2
and 4) or Ring1B (Fig. 3, top panel, lanes 7 and 9). FLAG-
tagged Rybp and FLAG-tagged Rybp(TF-AA) appear to be
expressed at similar levels (Fig. 3, lower panels), and the levels
of introduced Ring1A or Ring1B were not changed in the var-
ious transfection points (Fig. 3, middle panels). These results
suggest that Rybp’s interaction with Ring1A/B is likely up-
stream or independent of Rybp’s ability to recognize ubiquiti-
nated proteins via an intact NZF.
Next we assessed whether disruption of Rybp’s NZF UBD
alters its subcellular distribution pattern. Wildtype Rybp or
its TF-AA mutant was expressed in U2OS cells as YFP fu-
sions, and subcellular localization was determined by ﬂuores-
cent microscopy. As shown in Fig. 4A, YFP-Rybp assumed
a characteristic punctate pattern in the nucleoplasm, and was
also seen in larger subnuclear structures (Fig. 4A, left panel).
These structures also were observed, albeit to a minor extent,
when a CFP-Ring1B fusion protein was introduced by itself
(Fig. 4A, right panel), and likely represent PcG bodies which
have been reported previously to be sites for Ring1B and Rybp
co-localization (see [19]). YFP-Rybp(TF-AA) was nuclearly
Fig. 3. Rybp NZF-UBD mutations do not alter its interaction with the PcG proteins Ring1A and Ring1B. Western blotting analyses of FLAG-
immunoprecipitates from HeLa cells transfected with the indicated plasmids. Both Rybp and Rybp(TF-AA) interact similarly with Ring1A (as
detected by the anti-HA antibody, upper left panel, compare lanes 2 and 4) and Ring1B (detected by the anti-Myc antibody, upper right panel, lanes
7 and 9). All constructs express at comparable levels, as indicated by Western blotting analyses on total protein lysates using antibodies directed
against the HA tag (left, middle panel), against the Myc tag (right, middle panel), and against Rybp (bottom panels). Note that with slightly longer
exposure times, endogenous Rybp is detectable in the Western panels probed with the anti-Rybp antibody. Molecular weight is shown in kDa.
IP = immunoprecipitated; WB = Western blotting.
R. Arrigoni et al. / FEBS Letters 580 (2006) 6233–6241 6237localized like YFP-Rybp, although its localization pattern
comprised fewer discrete dots, and instead more aggregates
therein (Fig. 4A, middle panel). Notably, when YFP-Rybp
was co-introduced with CFP-Ring1B, the two proteins were
found to co-localize to more prominent PcG bodies (Fig. 4B,
upper row; see also [19]). In contrast, the YFP-Rybp(TF-AA)
mutant and CFP-Ring1B did not colocalize, and PcG bodies
were not seen (Fig. 4B, lower row). Western blotting analysis
conducted upon lysates from the cells transfected with the
various fusion proteins showed that YFP-Rybp and YFP-
Rybp(TF-AA) were expressed at levels comparable to those
of endogenous Rybp (see Fig. 4C, top panels), and that
CFP-Ring1B levels were comparable to those of endogenous
Ring1B (see Fig. 4C, bottom panels). Together, these immuno-
ﬂuorescence studies suggest that Rybp and Ring1B can co-
localize in PcG bodies when expressed together in U2OS cells,
and their overlapping pattern (and possibly the integrity of
PcG bodies) depends upon Rybp carrying an intact NZF do-
main. How the localization and co-localization diﬀerences ob-
served for the Rybp(TF-AA) mutant may relate to its inability
to bind to ubiquitinated proteins remains to be determined.
3.3. Rybp ubiquitination is enhanced by the ubiquitin E3 ligase
Ring1B
Having determined that Rybp is ubiquitinated and having
reconﬁrmed that it interacts with and can be found together
with Ring1B, we next asked whether Ring1B, a known ubiqui-
tin E3 ligase [28–31,44], could enhance the monoubiquitination
status of Rybp. For these assays (Fig. 5A), HeLa cells were
transfected with FLAG-tagged Rybp with or without ubiqui-
tin or Ring1B, and lysates were immunoprecipitated with the
anti-FLAG antibody and blotted with the anti-Rybp antibody.
The addition of ubiquitin to Rybp transfections results in the
appearance of the expected 48 kDa band that represents
Rybp with a single ubiquitin moiety attached (Fig. 5A, starred
band in lane 2). As reported previously for other ubiquitin
binding proteins (reviewed in [14]), only a minor fraction of
Rybp is ubiquitinated. However, when Ring1B is also added,
this fraction is clearly increased (Fig. 5A, compare lanes 3 to
2 for starred band). Supporting the fact that this band indeed
represents monoubiquitinated Rybp, when diﬀerent tags werefused to the introduced ubiquitin moiety (e.g., the Myc versus
the 6X-HIS tag), the band migrated in accordance with the dif-
ference in molecular weight of the tags themselves (Fig. 5A,
compare arrowed band in lane 4 to starred band in 3). Of note,
we also tested how the Rybp(TF-AA) ubiquitin-binding mu-
tant, which appears to have lost the ability to be monoubiqui-
tinated (Figs. 2B and 5B), responds to the presence of Ring1B.
Surprisingly, this mutant can become monoubiquitinated in
the presence of over-expressed Ring1B (Fig. 5B, compare lane
3 starred band to lane 2). Taken together, our results suggest
that Ring1B enhances the ubiquitination status of Rybp, and
(at least in the engineered TF-AA mutant) can also function
to uncouple Rybp’s ability to be post-translationally modiﬁed
from its ability to recognize ubiquitin. Whether Ring1B is a
bona ﬁde E3 ligase for Rybp, as it is for other proteins includ-
ing histone H2A [28–31], needs to be clariﬁed under more
physiological settings.
3.4. Ubiquitinated histone H2A is a potential target of Rybp’s
sensing mechanism
Next we tested whether Rybp is able to colocalize with
Ring1B and Ring1B’s substrate, ubiquitinated histone H2A,
on the inactive X chromosome in trophoblast stem (TS) cells
[28,29]. Immunoﬂuorescence analysis was performed on TS
cells using antibodies directed against Ring1B, Rybp, and
uH2A (Fig. 6A). Rybp was found to co-localize with Ring1B
in almost 100% of the cells examined, and both proteins
were concentrated on nuclear structures representing inactive
X chromosomes (Fig. 6A, upper row). Notably, extensive
co-localization of Rybp and uH2A at the inactive X was also
observed (Fig. 6A, bottom row).
To pursue the uH2A-Rybp connection further, we asked
whether ubiquitinated histone H2A could be a target for
Rybp’s ubiquitin binding activity. Nucleosomal histones were
prepared and tested for interaction with recombinant GST-
Rybp, GST-Rybp(TF-AA), or GST alone as a negative con-
trol (Fig. 6B and data not shown). Western blotting analysis
showed that GST-Rybp can bind both to unmodiﬁed histone
H2A and to ubiquitinated histone H2A (Fig. 6B, lane 2, upper
and lower panels). In contrast, the interaction of GST-
Rybp(TF-AA) with unmodiﬁed histone H2A was signiﬁcantly
Fig. 4. Rybp NZF-UBD mutations aﬀect its sub-nuclear localization and its colocalization with Ring1B. (A) and (B) representative ﬂuorescent
microscopy images of transfected U2OS cells, the majority of which exhibited the patterns shown here. In (A), YFP-Rybp, YFP-Rybp(TF-AA), or
CFP-Ring1B was introduced alone. In (B), YFP-Rybp or YFP-Rybp(TF-AA) was co-introduced with CFP-Ring1B. (C) Western blotting analyses
of protein lysates from U2OS cells transfected with the indicated fusion constructs, using antibodies directed against Rybp (upper panels) or Ring1B
(lower panels). Endogenous (non-tagged) protein levels are shown in separate panels. Molecular weight is shown in kDa on the left. WB = Western
blotting; NS = non-speciﬁc.
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undetectable (Fig. 6B, lane 3, upper and lower panels). No
binding was seen for pull-downs performed with GST alone
(data not shown). Taken together, these ﬁndings suggest that
ubiquitinated histone H2A is a potential target of Rybp’s ubi-
quitin-binding activity. The fact that Rybp can also bind to
unmodiﬁed histone H2A is not surprising given that ubiquitin
binding proteins are believed to establish additional protein
contacts (aside from with the ubiquitin moiety) to increase
the aﬃnity and speciﬁcity for their targets [14].
3.5. Implications
By establishing here that Rybp’s ubiquitination status can be
enhanced by Ring1B (Fig. 5), and that Rybp may inﬂuenceRing1B’s subcellular localization in an NZF-dependent man-
ner (Fig. 4), we have provided potential molecular explana-
tions for the reported association of Rybp with PcG
proteins. Our ﬁnding that one possible target of Rybp’s NZF
is ubiquitinated histone H2A (Fig. 6B) supports a possibly
more active role for Rybp in PcG-mediated transcriptional
repression. In particular, histone H2A ubiquitination has been
shown to be mediated, at least in part, by Ring1B, and this
modiﬁcation has been linked to PcG-mediated gene silencing
including the X inactivation process [28–31]. Our data from
the trophoblast stem cell studies, demonstrating colocalization
on the inactive X of Rybp, Ring1B, and ubH2A (Fig. 6A), sug-
gest that Rybp may also be participating in gene silencing of
the X chromosome. Finally, we cannot rule out the possibility
Fig. 5. The ubiquitin E3 ligase Ring1B enhances Rybp monoubiquitination. Western blotting analysis of FLAG immunoprecipitates of HeLa cells
transfected with the indicated plasmids, including wildtype Rybp in (A) and the Rybp(TF-AA) mutant in (B). Monoubiquitinated Rybp forms are
marked by asterisks, and unmodiﬁed introduced Rybp forms are indicated. The monoubiquitinated Rybp band migrates more slowly (arrowed band
in lane 4) when 6XHis-Ub is introduced instead of Ub-myc. Ub = ubiquitin; WB = Western Blot; IP = immunoprecipitated.
Fig. 6. Rybp and uH2A interact in vitro and co-localize in trophoblast stem cells. (A) Immunoﬂuorescence analysis of trophoblast stem (TS) cells
using antibodies directed against Ring1B (green, upper row), ubiquitinated histone H2A (green, lower row) and Rybp (red). Nuclei of TS cells were
stained using DAPI (blue). Co-localization of Ring1B and Rybp or of uH2A and Rybp is seen as a yellow signal in the merge panels. This
colocalization is especially apparent on the inactive X chromosome (bright spots). 63· magniﬁcation, with oil. (B) Western blotting analysis of pull-
down experiments using GST-Rybp (lane 2) or GST-Rybp(TF-AA) (lane 3) incubated with nuclear pellet fractions from HeLa cells, and probed with
antibodies against ubiquityl-histone H2A (upper panel) or histone H2A (lower panel). Ubiquitinated (uH2A) and non-modiﬁed (H2A) histone H2A
are indicated on the right. A fraction of the input proteins is also shown (lane 1, 1/2 input was loaded in the upper panel, and 1/4 input was loaded in
the lower panel). Molecular weights are indicated in kDa on the left. WB = Western blot.
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plex, such as promoting protein–protein interactions betweenPRC1 members, modifying the activities of these proteins, or
targeting the complex to other factors or to speciﬁc subcellular
6240 R. Arrigoni et al. / FEBS Letters 580 (2006) 6233–6241compartments (the latter is also suggested from the results of
Fig. 4).
A pressing future objective is to identify the spectrum of cel-
lular ubiquitinated proteins that are recognized by Rybp and
its NZF UBD; the collection of known Rybp interacting pro-
teins and Rybp-containing protein complexes provides likely
candidates for this (see [19,45–50]). If the modiﬁcation status
of these candidate interacting proteins is indeed ‘‘read’’ by
Rybp, then this would help to explain why Rybp is able to
interact with a wide variety of proteins localized to distinct
subcellular compartments including Polycomb group proteins
[19,48], DNA binding transcription factors [19,45,46,48], and
apoptotic proteins [47,49]. Beyond the identiﬁcation of target
proteins, the precise functional consequences of Rybp’s bind-
ing to these modiﬁed proteins remain to be elucidated.
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